Cardiology Biobank Registry

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria shortened, about 3 wordsv18
  2. Minor Site contact updatedv17
  3. 2 versions Re-verified since May 1, 2023, no change to tracked fieldsv15-v16
  4. Minor Study description expanded, about 369 wordsv14
  5. Re-verified, no change to tracked fieldsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Notable Primary and study completion dates pushed to Apr 2030v12
  2. Minor Eligibility criteria expanded, about 84 wordsv11
  3. Re-verified, no change to tracked fieldsv10
  4. Minor Site contact updatedv9
  5. 4 versions Re-verified since Dec 12, 2014, no change to tracked fieldsv5-v8
  6. Study Status, Outcome Measuresv4
  7. Re-verified, no change to tracked fieldsv3
  8. Minor Primary completion date: Mar 2020v2 Show 5 more changesShow less
    • Study completion date: Apr 2020
    • Start date: Dec 2003
    • Site contact updated
    • Eligibility criteria shortened, about 3 words
    • Study title expanded, about 1 word
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
8,870 trials monitored
See 440 trials at risk
In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers. Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively. By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.
Trial Details
NCT Number NCT00378924
Lead Sponsor Emory University
Conditions
(from sponsor)
Cardiovascular Disease
Related terms Cardiovascular Diseases
Enrollment 12,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov